Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral useM Clozel, H Ramuz, J P Clozel, et al.Science (New York, N.Y.)|July 14, 1989
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injuryJ S Powell, J P Clozel, R K Müller, et al.The American Journal of Physiology|April 1, 1995
Voltage-gated calcium currents have two opposing effects on the secretion of aldosteroneP Q Barrett, E A Ertel, M M Smith, et al.American Journal of Hypertension|February 1, 1994
Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertensionE Eng, M Veniant, J Floege, et al.British Journal of Clinical Pharmacology|March 16, 2000
Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirinB Wittke, H Ensor, J Chung, et al.Journal of the American College of Cardiology|February 1, 1997
Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failureP Mulder, V Richard, P Compagnon, et al.Molecular Pharmacology|December 1, 1992
High affinity block of myocardial L-type calcium channels by the spider toxin omega-Aga-toxin IIIA: advantages over 1,4-dihydropyridinesC J Cohen, E A Ertel, M M Smith, et al.Biochemistry|May 3, 1994
Type III omega-agatoxins: a family of probes for similar binding sites on L- and N-type calcium channelsE A Ertel, V A Warren, M E Adams, et al.Circulation|July 1, 1995
Role of endogenous endothelin-1 in experimental renal hypertension in dogsJ Donckier, L Stoleru, W Hayashida, et al.Circulation Research|January 24, 1998
Local angiotensin II generation in the rat heart: role of renin uptakeD N Müller, W Fischli, J P Clozel, et al.Pageof 15